Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03373097
What this trial is testing

Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors

Who this might be right for
NeuroblastomaNeuroblastoma RecurrentGD2-positive Solid Tumors+3 more
Bambino Gesù Hospital and Research Institute 42
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774
What this trial is testing

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Malignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03709680
What this trial is testing

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Who this might be right for
Ewing SarcomaSolid TumorsRhabdoid Tumor+4 more
Pfizer 128
Very early researchEnded earlyNCT04213794
What this trial is testing

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients

Who this might be right for
Malignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more
Mayo Clinic 2
Not applicableWithdrawnNCT00624962
What this trial is testing

Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLeukemia+4 more
Vanderbilt University
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)UnknownNCT00179816
What this trial is testing

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

Who this might be right for
Ewing's SarcomaSoft Tissue SarcomaHepatoblastoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 12
Early research (Phase 1)Looking for participantsNCT07584499
What this trial is testing

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Nasopharyngeal CarcinomaLymphoepithelial Carcinoma+7 more
Sun Yat-sen University 51
Testing effectiveness (Phase 2)Ended earlyNCT04145700
What this trial is testing

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma

Who this might be right for
Synovial Sarcoma
Eli Lilly and Company 23
Early research (Phase 1)Study completedNCT02315612
What this trial is testing

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Who this might be right for
NHLLarge Cell LymphomaFollicular Lymphoma+7 more
National Cancer Institute (NCI) 134
Not applicableLooking for participantsNCT05697874
What this trial is testing

International Rare Brain Tumor Registry

Who this might be right for
AstroblastomaBCOR ITD SarcomaCNS Sarcoma+1 more
Children's National Research Institute 5,800
Testing effectiveness (Phase 2)Looking for participantsNCT06456892
What this trial is testing

Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen

Who this might be right for
RhabdomyosarcomaPediatric Cancer
Sun Yat-sen University 82
Not applicableStudy completedNCT03686566
What this trial is testing

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

Who this might be right for
NeuroblastomaSarcomaPediatric Cancer
University of Texas Southwestern Medical Center 84
Testing effectiveness (Phase 2)Looking for participantsNCT06094101
What this trial is testing

Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)

Who this might be right for
Ewing SarcomaRhabdomyosarcomaSynovial Sarcoma
University Hospital Tuebingen 30
Early research (Phase 1)Study completedNCT02601937
What this trial is testing

EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Who this might be right for
Rhabdoid TumorsINI1-negative TumorsSynovial Sarcoma+1 more
Epizyme, Inc. 109
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo
Large-scale testing (Phase 3)Looking for participantsNCT06836492
What this trial is testing

A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

Who this might be right for
RhabdomyosarcomaPediatric Cancer
Yizhuo Zhang 300